Transmitted through the sharing of needles, syringes and other injecting equipment, hepatitis C is the most common infectious disease among injecting drug users in Europe today.In this analysis, the EMCDDA looks at some of the positive advances in treating the disease, including a new generation of medicines.
Part of the ‘Perspectives on drugs’ (PODs) series, launched alongside the annual European Drug Report, these designed-for-the-web interactive analyses aim to provide deeper insights into a selection of important issues.
Fondaz LILA Milano @LILAMilano
Mon, 09/16/2019 - 12:02
RT @aidsactioneurop: The European HIV/AIDS Archive has been lauched today as one outcome of the @europach_hera project at the #EUROPACH Clo…
Dr Emily Jay Nicholls @ejnicholls_
Thu, 09/12/2019 - 14:56
RT @aidsactioneurop: #EUROPACH Closing Conference "Living Politics: Remembering #HIVAIDS Activism Tomorrow" just started! We are happy to p…
Meaghan Kall 🏳️🌈🇪🇺 @kallmemeg
Wed, 09/11/2019 - 18:32
@JVLazarus @HIVOutcomes @ProfJAnderson @EATGx @aidsactioneurop @ECUO_org @AFEW_Int @TheLancetHIV @RHardingCSI… https://t.co/E8vWOvx4id
Jeffrey V. Lazarus @JVLazarus
Wed, 09/11/2019 - 13:21
@HIVOutcomes @ProfJAnderson @EATGx @aidsactioneurop @ECUO_org @AFEW_Int Sorry to miss #FTC2019 - already in Montrea… https://t.co/1j5Lwnx67h
